High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE4
Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma
- Status
- UNKNOWN
- Phase
- NA
LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive
- Status
- COMPLETED
- Phase
- PHASE4
Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
LAL-BR/2001: Study Treatment to Low Risk ALL
- Status
- COMPLETED
- Phase
- PHASE4
Non-Myeloablative Allogeneic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
CFAR Study in Patients With Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Study of NY-ESO-1 ISCOMATRIX® in Patients With Measurable Stage III or IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Doxorubicin or Epirubicin and Cyclophosphamide in Treating Older Women With Invasive Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Vincristine Sulfate, Topotecan Hydrochloride, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma
- Status
- WITHDRAWN
- Phase
- NA
Primary Breast Cancer Occurring Concomitant With Pregnancy
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Anti-gp100:154-162 TCR Gene Engineered Lymphocytes
- Status
- TERMINATED
- Phase
- PHASE2